DK381583A - Metylsubstituerede 4-metoxypyridin-n-oxyder - Google Patents

Metylsubstituerede 4-metoxypyridin-n-oxyder Download PDF

Info

Publication number
DK381583A
DK381583A DK381583A DK381583A DK381583A DK 381583 A DK381583 A DK 381583A DK 381583 A DK381583 A DK 381583A DK 381583 A DK381583 A DK 381583A DK 381583 A DK381583 A DK 381583A
Authority
DK
Denmark
Prior art keywords
substituted
metoxypyridine
oxyder
methyl
sub
Prior art date
Application number
DK381583A
Other languages
English (en)
Other versions
DK381583D0 (da
Inventor
Arne Elof Braendstroem
Bo Robert Lamm
Original Assignee
Haessle Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20347627&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK381583(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Haessle Ab filed Critical Haessle Ab
Publication of DK381583D0 publication Critical patent/DK381583D0/da
Publication of DK381583A publication Critical patent/DK381583A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/89Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/68One oxygen atom attached in position 4
DK381583A 1982-08-26 1983-08-19 Metylsubstituerede 4-metoxypyridin-n-oxyder DK381583A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8204879A SE8204879D0 (sv) 1982-08-26 1982-08-26 Novel chemical intermediates

Publications (2)

Publication Number Publication Date
DK381583D0 DK381583D0 (da) 1983-08-19
DK381583A true DK381583A (da) 1984-02-27

Family

ID=20347627

Family Applications (1)

Application Number Title Priority Date Filing Date
DK381583A DK381583A (da) 1982-08-26 1983-08-19 Metylsubstituerede 4-metoxypyridin-n-oxyder

Country Status (28)

Country Link
US (2) US4544750A (da)
EP (1) EP0103553B1 (da)
JP (1) JPS5959662A (da)
KR (1) KR880000091B1 (da)
AT (1) ATE40884T1 (da)
AU (1) AU560028B2 (da)
CA (1) CA1234118A (da)
CY (1) CY1328A (da)
DD (1) DD233126A5 (da)
DE (2) DE103553T1 (da)
DK (1) DK381583A (da)
ES (1) ES8404993A1 (da)
FI (1) FI79701C (da)
GB (1) GB2126226B (da)
GR (1) GR79374B (da)
HK (1) HK19486A (da)
HU (1) HU189738B (da)
IE (1) IE55865B1 (da)
IL (1) IL69175A (da)
IS (1) IS1438B6 (da)
MY (1) MY8600503A (da)
NO (1) NO164093C (da)
NZ (1) NZ204959A (da)
OA (1) OA07498A (da)
PH (1) PH17786A (da)
PT (1) PT77249B (da)
SE (1) SE8204879D0 (da)
ZA (1) ZA835143B (da)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8404065D0 (sv) * 1984-08-10 1984-08-10 Haessle Ab Novel biologically active compounds
SE8504409D0 (sv) * 1985-09-24 1985-09-24 Haessle Ab Novel chemical intermediates
DE3783503T2 (de) * 1986-04-17 1993-05-13 Ici Plc Pyridylacrylsaeureester-derivate, verfahren zu ihrer herstellung und ihre verwendung als fungizide.
US5221316A (en) * 1986-04-17 1993-06-22 Imperial Chemical Industries Plc Fungicides
US4920230A (en) * 1987-06-29 1990-04-24 Takeda Chemical Industries, Ltd. Method of producing nitrogen-containing heteroaromatic compounds having an alkoxy group
AT391693B (de) * 1988-11-15 1990-11-12 Cl Pharma Verfahren zur herstellung von 3-5-dimethyl-4methoxypyridinderivaten sowie neues zwischenprodukt hierfuer
US4965269A (en) * 1989-12-20 1990-10-23 Ab Hassle Therapeutically active chloro substituted benzimidazoles
ES2026761A6 (es) * 1990-10-31 1992-05-01 Genesis Para La Investigacion Procedimiento de obtencion del omeprazol.
ES2036948B1 (es) * 1991-11-21 1994-09-01 Genesis Para La Investigacion Procedimiento de obtencion de compuestos derivados de piridina.
ES2060541B1 (es) * 1993-02-26 1995-11-16 Vinas Lab Nuevo procedimiento para la sintesis de un derivado de 2-(2-piridilmetilsufinil) bencimidazol, y nuevos productos intermedios obtenidos con el mismo.
SE9301830D0 (sv) * 1993-05-28 1993-05-28 Ab Astra New compounds
ES2097089B1 (es) * 1995-02-01 1997-12-16 Esteve Quimica Sa Procedimiento para la preparacion de 2-hidroximetil-3,5-dimetil-4-metoxipiridina.
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US6699885B2 (en) 1996-01-04 2004-03-02 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and methods of using same
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US6645988B2 (en) 1996-01-04 2003-11-11 Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
CA2204580A1 (en) * 1997-05-06 1998-11-06 Michel Zoghbi Synthesis of pharmaceutically useful pyridine derivatives
WO1999033807A2 (en) * 1997-12-24 1999-07-08 Pdi-Research Laboratories, Inc. Synthesis of pharmaceutically useful pyridine derivatives (intermediates) employing free radical substitution reactions to functionalize the 2-position of the pyridine
US6437139B1 (en) 1997-05-06 2002-08-20 Pdi-Research Laboratories, Inc. Synthesis of pharmaceutically useful pyridine derivatives
GB9717849D0 (en) * 1997-08-23 1997-10-29 Seal Sands Chemicals Limited Preparation of pyridene derivatives
US6174548B1 (en) 1998-08-28 2001-01-16 Andrx Pharmaceuticals, Inc. Omeprazole formulation
US6096340A (en) * 1997-11-14 2000-08-01 Andrx Pharmaceuticals, Inc. Omeprazole formulation
US6350876B2 (en) 1998-01-26 2002-02-26 Kuraray Co., Ltd. 4-chloro-3,5-dimethyl-2-sulfonyl pyridines
US6197962B1 (en) 1998-01-26 2001-03-06 Kuraray Co., Ltd. Method for producing 2-sulfonylpyridine derivatives and method for producing 2-{[(2-pyridyl)methyl]thio}-1H-benzimidazole derivatives
US6303787B1 (en) 1998-05-27 2001-10-16 Natco Pharma Limited Intermediates and an improved process for the preparation of Omeprazole employing the said intermediates
WO2000000474A1 (en) * 1998-06-26 2000-01-06 Russinsky Limited Pyridine building blocks as intermediates in the synthesis of pharmaceutically active compounds
US6733778B1 (en) 1999-08-27 2004-05-11 Andrx Pharmaceuticals, Inc. Omeprazole formulation
US6353005B1 (en) 1999-03-02 2002-03-05 Sepracor, Inc. Method and compositions using (+) norcisapride in combination with proton pump inhibitors or H2 receptor antagonist
US6362202B1 (en) 1999-03-02 2002-03-26 Sepracor Inc. Methods and compositions using (−) norcisapride in combination with proton pump inhibitors or H2 receptor antagonists
US6555139B2 (en) 1999-06-28 2003-04-29 Wockhardt Europe Limited Preparation of micron-size pharmaceutical particles by microfluidization
US6245913B1 (en) 1999-06-30 2001-06-12 Wockhardt Europe Limited Synthetic procedure for 5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methylthio]-IH-benzimidazole hydrochloride and its conversion to omeprazole
US6312723B1 (en) 1999-08-26 2001-11-06 Robert R. Whittle Pharmaceutical unit dosage form
US6316020B1 (en) 1999-08-26 2001-11-13 Robert R. Whittle Pharmaceutical formulations
US6326384B1 (en) 1999-08-26 2001-12-04 Robert R. Whittle Dry blend pharmaceutical unit dosage form
US6268385B1 (en) 1999-08-26 2001-07-31 Robert R. Whittle Dry blend pharmaceutical formulations
US6312712B1 (en) 1999-08-26 2001-11-06 Robert R. Whittle Method of improving bioavailability
US6262085B1 (en) 1999-08-26 2001-07-17 Robert R. Whittle Alkoxy substituted Benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6262086B1 (en) 1999-08-26 2001-07-17 Robert R. Whittle Pharmaceutical unit dosage form
US6369087B1 (en) 1999-08-26 2002-04-09 Robert R. Whittle Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6780880B1 (en) 1999-08-26 2004-08-24 Robert R. Whittle FT-Raman spectroscopic measurement
GB9921578D0 (en) * 1999-09-13 1999-11-17 Cipla Limited Omeprazole synthesis
ES2171116B1 (es) * 2000-04-14 2003-08-01 Esteve Quimica Sa Procedimiento para la obtencion de derivados de (((piridil sustituido)metil)tio)bencimidazol.
AU2000258410A1 (en) * 2000-07-28 2003-12-02 Herbex, Produtos Quimicos, Sa New method for the preparation of the anti-ulcer compounds omeprazole, lansoprazole and pantoprazole
EA009590B1 (ru) 2001-05-11 2008-02-28 Тиботек Фармасьютикалз Лтд. 2-аминобензоксазолсульфонамидные ингибиторы вич-протеазы широкого спектра
CA2472103A1 (en) * 2002-01-25 2003-08-07 Santarus, Inc. Transmucosal delivery of proton pump inhibitors
FR2848555B1 (fr) 2002-12-16 2006-07-28 Negma Gild Enantiomere(-)du tenatoprazole et son application en therapeutique
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8815916B2 (en) 2004-05-25 2014-08-26 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
CN100376574C (zh) * 2006-06-14 2008-03-26 浙江大学 泰妥拉唑的制备方法
EA200900985A1 (ru) 2007-01-31 2009-12-30 Крка, Товарна Здравил, Д. Д., Ново Место Способ получения оптически чистого омепразола
CN101648907B (zh) * 2009-09-14 2011-08-03 南京第一农药集团有限公司 2-氯甲基-4-甲氧基-3,5-二甲基吡啶盐酸盐的纯化方法
CN101648912B (zh) * 2009-09-14 2012-07-04 南京第一农药集团有限公司 一种4-硝基-3,5-二甲基吡啶-n-氧化物的连续化制备方法
CN102603620B (zh) * 2012-01-13 2014-10-29 江苏中邦制药有限公司 一种氯甲基吡啶或其吡啶衍生物盐酸盐的合成方法
CN114364389A (zh) 2019-09-24 2022-04-15 普罗莱克塔生物科学公司 用于治疗炎性和免疫疾病的组合物和方法
CN112142653B (zh) * 2020-10-22 2022-02-11 成都百泉生物医药科技有限公司 奥美拉唑中间体的制备方法
CN113307773A (zh) * 2021-06-17 2021-08-27 上海毕得医药科技股份有限公司 6-溴-3-甲氧基-1-苯基-1h-吲唑及其合成方法和应用
CN114805193B (zh) * 2022-04-19 2023-06-20 南京红太阳医药研究院有限公司 一种奥美拉唑中间体的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2735851A (en) * 1956-02-21 Alkanolpykroine-n-oxides
US2663711A (en) * 1951-12-08 1953-12-22 Du Pont Process for the preparation of pyridine alcohols from pyridine n-oxides
GB1564502A (en) * 1975-07-31 1980-04-10 Smith Kline French Lab Guanidines thioureas and 1,1-diamino-2-nitroethylene derivatives
SE7804231L (sv) * 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
KR840002371A (ko) * 1981-11-05 1984-06-25 귄터 미카엘, 헤르페르트 수키 치환된 벤즈 이미다졸의 제조방법
US4472409A (en) * 1981-11-05 1984-09-18 Byk Gulden Lomberg Chemische Fabrik Gesellschaft Mit Beschrankter Haftung 2-Pyridylmethyl thio(sulfinyl)benzimidazoles with gastric acid secretion inhibiting effects

Also Published As

Publication number Publication date
ZA835143B (en) 1984-04-25
IL69175A0 (en) 1983-11-30
PT77249A (en) 1983-09-01
AU560028B2 (en) 1987-03-26
OA07498A (en) 1985-03-31
IE831787L (en) 1984-02-26
NO832794L (no) 1984-02-27
GB2126226B (en) 1985-09-18
GR79374B (da) 1984-10-22
FI833047A0 (fi) 1983-08-25
GB8322866D0 (en) 1983-09-28
FI79701B (fi) 1989-10-31
EP0103553A1 (en) 1984-03-21
US4544750A (en) 1985-10-01
MY8600503A (en) 1986-12-31
US4620008A (en) 1986-10-28
PH17786A (en) 1984-12-13
DE3379222D1 (en) 1989-03-30
SE8204879D0 (sv) 1982-08-26
IL69175A (en) 1987-01-30
NO164093C (no) 1990-08-29
KR880000091B1 (ko) 1988-02-23
DD233126A5 (de) 1986-02-19
AU1710183A (en) 1984-03-01
DE103553T1 (de) 1984-09-27
IS2845A7 (is) 1984-02-27
FI79701C (fi) 1990-02-12
CY1328A (en) 1986-06-27
JPS6353987B2 (da) 1988-10-26
EP0103553B1 (en) 1989-02-22
FI833047A (fi) 1984-02-27
JPS5959662A (ja) 1984-04-05
ES525122A0 (es) 1984-05-16
KR840005718A (ko) 1984-11-15
IE55865B1 (en) 1991-01-30
HK19486A (en) 1986-03-27
ES8404993A1 (es) 1984-05-16
ATE40884T1 (de) 1989-03-15
HU189738B (en) 1986-07-28
NZ204959A (en) 1985-12-13
DK381583D0 (da) 1983-08-19
PT77249B (en) 1986-07-14
CA1234118A (en) 1988-03-15
GB2126226A (en) 1984-03-21
IS1438B6 (is) 1990-09-25
NO164093B (no) 1990-05-21

Similar Documents

Publication Publication Date Title
DK381583D0 (da) Metylsubstituerede 4-metoxypyridin-n-oxyder
FI853625L (fi) Tetralinderivat, deras framstaellning och anvaendning.
MX9203338A (es) Nuevos derivados del oxico a_nor-esteroide-3-carboxilico.
ES479206A1 (es) Un procedimiento para la preparacion de n-heterociclil-4- piperidinamina.
FI852974A0 (fi) Nya n-hydroxylgruppen skyddande grupper och framstaellningsfoerfarande foer 3-acylamino-1-hydroxi-2-azetidinoner.
GR900100380A (el) Μέ?οδος παρασκευής αντι-φλεγμονωδών παραγώγων αμινοφενόλης.
FI812635L (fi) Piperidylidenderivat deras framstaellning och dessa innehaollande farmaceutiska blandningar
GR880100869A (el) Μέ?οδος παρασκευής παραγώγων υποκατεστημένου στυρολίου.
ES553412A0 (es) Un procedimiento para la produccion de derivados de benzoilurea
GR1000887B (el) Νεα παραγωγα σπιροφουρανης.
IT1201481B (it) Pantotenil derivati
IT1121010B (it) Procedimento per la carbonilazione di diolefine
FI821141L (fi) 5,6-dihydro-11-alkylen-morfantridin-6-one, deras framstaellning och dessa innehaollande laekemedel
GR1000471B (el) Μεθοδος παρασκευης κινολινοθειοαιθερων.
FI832818A (fi) Foerfarande foer framstaellning av alfa- substituerade alkylarylketaler.
JPS5283532A (en) Novel aromatic compounds
GR1000138B (el) Νεα παραγωγα ριβοφουρανουρονικου οξεος, μεθοδος δια την παρασευη αυτων και η χρησιμοποιησις αυτων.

Legal Events

Date Code Title Description
ARF Application refused
ARF Application refused